Egyptian Journal of Chest Diseases and Tuberculosis
Scope & Guideline
Exploring breakthroughs in chest diseases and tuberculosis management.
Introduction
Aims and Scopes
- Pulmonary Infectious Diseases:
The journal emphasizes research on infectious diseases affecting the lungs, particularly tuberculosis, COVID-19, and other respiratory infections. This includes studies on diagnosis, treatment, and management strategies. - Chronic Respiratory Diseases:
Research on chronic conditions such as chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases is a core focus. The journal publishes studies that investigate pathophysiology, management, and rehabilitation of these diseases. - Diagnostic Innovations:
There is a strong focus on novel diagnostic techniques, including imaging (e.g., ultrasound, CT), biomarker studies, and advanced laboratory methods for detecting respiratory diseases, which contribute to better patient outcomes. - Therapeutic Interventions:
The journal covers a range of therapeutic approaches, including pharmacological treatments, surgical interventions, and rehabilitation strategies. It particularly addresses the effectiveness of new therapies and treatment protocols. - Occupational and Environmental Health:
The impact of occupational exposures and environmental factors on respiratory health is explored, particularly in relation to specific populations such as healthcare workers and industrial workers. - Public Health and Epidemiology:
The journal also includes studies on the epidemiology of respiratory diseases, public health initiatives, and strategies for controlling infectious diseases within communities.
Trending and Emerging
- COVID-19 Research:
There is a significant increase in publications related to COVID-19, focusing on its respiratory complications, long-term effects, and management strategies, which have become critical due to the pandemic. - Antimicrobial Resistance:
Research on antimicrobial resistance, particularly in tuberculosis and other respiratory pathogens, is gaining prominence as global health authorities prioritize combating drug-resistant infections. - Telemedicine and Remote Monitoring:
The rise of telemedicine, particularly in managing respiratory diseases during the pandemic, is reflected in recent publications, emphasizing the need for innovative care delivery models. - Personalized Medicine:
Emerging studies on personalized medicine approaches in treating respiratory diseases, including the use of biomarkers for targeted therapies, are increasingly featured. - Public Health Interventions:
There is a growing emphasis on studies related to public health interventions aimed at controlling respiratory diseases, including vaccination campaigns and community health strategies. - Occupational Health Studies:
Research examining the effects of occupational exposures on respiratory health is trending, particularly studies involving specific professions and environmental impacts.
Declining or Waning
- Traditional Diagnostic Methods:
There has been a noticeable decrease in studies focusing solely on conventional diagnostic methods such as basic spirometry and chest X-rays, as the field moves towards more advanced imaging and molecular techniques. - Tuberculosis Treatment Protocols:
Research specifically on older protocols for tuberculosis treatment appears to be declining, possibly due to the increasing focus on drug resistance and novel therapeutic regimens. - Pediatric Respiratory Conditions:
The focus on pediatric respiratory diseases, while still important, has diminished in favor of adult respiratory health issues, particularly in the context of chronic diseases and COVID-19. - Non-communicable Respiratory Diseases:
Research on non-communicable diseases of the lungs, such as lung cancer, has seen a relative decline in favor of infectious diseases, particularly in light of the recent COVID-19 pandemic.
Similar Journals
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Exploring the frontiers of pulmonary medicine and patient care.American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.
BMJ Open Respiratory Research
Advancing respiratory health through innovative research.BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.
Lung India
Advancing respiratory health through accessible research.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.
Annals of Thoracic Medicine
Exploring innovations in cardiology and pulmonary medicine.Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.
Multidisciplinary Respiratory Medicine
Connecting researchers and practitioners in respiratory health.Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.
Pulmonary Medicine
Advancing the Frontiers of Respiratory HealthPulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.
Respiratory Investigation
Shaping tomorrow's respiratory practices today.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
Zeitschrift fur Pneumologie
Empowering Knowledge for Better Respiratory CareZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.
Egyptian Journal of Bronchology
Unveiling breakthroughs in bronchology for global impact.Egyptian Journal of Bronchology, published by SPRINGER, is a premier open access journal dedicated to advancing the field of respiratory medicine, particularly focusing on bronchial diseases and disorders. Since its establishment in 2013, this journal has provided a platform for the dissemination of high-quality research articles, systematic reviews, and clinical studies, making significant contributions to the understanding and management of bronchological conditions. With its commitment to open access, the journal ensures that research findings are readily available to a global audience, fostering knowledge exchange among researchers, healthcare professionals, and students alike. The Egyptian Journal of Bronchology serves as an essential resource in the field, reflecting a growing emphasis on accessible scientific knowledge and collaborative research in respiratory health.
LUNG
Exploring the complexities of lung diseases for better patient outcomes.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.